 |
|
Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Georg Semmler, Christian Datz, Michael Trauner
Clin Mol Hepatol. 2023;29(Suppl):S244-S260. Published online 2022 Dec 14 DOI: https://doi.org/10.3350/cmh.2022.0364
|
|
Citations to this article as recorded by
 Effect of Nut Consumption on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Ling Pan, Jing Sui, Ying Xu, Qun Zhao
Nutrients.2023; 15(10): 2394. CrossRef Synergistic Effect of Diet and Physical Activity on a NAFLD Cohort: Metabolomics Profile and Clinical Variable Evaluation
Francesco Maria Calabrese, Giuseppe Celano, Caterina Bonfiglio, Angelo Campanella, Isabella Franco, Alessandro Annunziato, Gianluigi Giannelli, Alberto Ruben Osella, Maria De Angelis
Nutrients.2023; 15(11): 2457. CrossRef Diet and non-alcoholic fatty liver disease, a short narrative review
W.J. Kwanten
Acta Gastro Enterologica Belgica.2023; 86(2): 306. CrossRef β-hydroxybutyrate: A crucial therapeutic target for diverse liver diseases
Ke Li, Wen-hong Wang, Jia-bin Wu, Wei-hua Xiao
Biomedicine & Pharmacotherapy.2023; 165: 115191. CrossRef Ramadan fasting model exerts hepatoprotective, anti-obesity, and anti-hyperlipidemic effects in an experimentally-induced nonalcoholic fatty liver in rats
Abeer A. Alasmari, Abdulrahman S. Al-Khalifah, Ahmed S. BaHammam, Noura M. S. Alshiban, Ahmad T. Almnaizel, Hesham S. Alodah, Maha H. Alhussain
Saudi Journal of Gastroenterology.2023;[Epub] CrossRef
|